Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MGTX
#2386
MeiraGTx Holdings plc Ordinary Shares
7.560
0
+0.67%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.67%
Monthly Change
-5.50%
6 month change
-13.60%
Year Change
-13.60%
Previous Close
7.510
0
Open
7.560
0
Bid
Ask
Low
7.560
0
High
7.560
0
Volume
45
Markets
US Stock Market
Healthcare
MGTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
MeiraGTx stock rises on exclusive licensing deal with ZipBio for eye disease therapy
MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy
Truist Securities raises Eli Lilly stock price target to $1,182 on obesity drug outlook
JPMorgan raises Eli Lilly stock price target to $1,150 on obesity drug outlook
MeiraGTx stock price target raised to $16 from $12 at RBC Capital
MeiraGTx earnings missed by $0.13, revenue fell short of estimates
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates
MeiraGTx stock price target raised to $30 by Piper Sandler on Eli Lilly deal
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
Eli Lilly signs deal for MeiraGTx’s gene therapy for severe eye disease
MeiraGTx and Lilly partner on gene therapy for blindness in $75m deal